2018
Therapeutic potential of omega-3 fatty acid-derived epoxyeicosanoids in cardiovascular and inflammatory diseases.
Schunck, W.H., Konkel, A., Fischer, R. and Weylandt, K.H.
Pharmacology & Therapeutics 183
: 177-204.
March 2018
2017
A diet rich in Omega-3 fatty acids enhances expression of soluble epoxide hydrolase in murine brain.
Ostermann, A.I., Reutzel, M., Hartung, N., Franke, N., Kutzner, L., Schoenfeld, K., Weylandt, K.H., Eckert, G.P. and Schebb, N.H.
Prostaglandins & Other Lipid Mediators 133
: 79-87.
November 2017
Effect of different lipid apheresis methods on plasma polyunsaturated fatty acids.
Schmoecker, C., Kassner, U., Ostermann, A.I., Kiesler, S., Steinhagen-Thiessen, E., Schebb, N.H. and Weylandt, K.H.
Atherosclerosis Supplements 30
: 193-199.
November 2017
Modulation of the endogenous omega-3 fatty acid and oxylipin profile in vivo - a comparison of the fat-1 transgenic mouse with C57BL/6 wildtype mice on an omega-3 fatty acid enriched diet.
Ostermann, A.I., Waindok, P., Schmidt, M.J., Chiu, C.Y., Smyl, C., Rohwer, N., Weylandt, K.H. and Schebb, N.H.
PLoS ONE 12
(9): e0184470.
8 September 2017
Quantitative profiling of hydroxy lipid metabolites in mouse organs reveals distinct lipidomic profiles and modifications due to elevated n-3 fatty acid levels.
Chiu, C.Y., Smyl, C., Dogan, I., Rothe, M. and Weylandt, K.H.
Biology 6
(1): E9.
4 February 2017
The effect of omega-3 fatty acids on central nervous system remyelination in fat-1 mice.
Siegert, E., Paul, F., Rothe, M. and Weylandt, K.H.
BMC Neuroscience 18
(1): 19.
24 January 2017
Malnutrition predicts clinical outcome in patients with neuroendocrine neoplasias.
Maasberg, S., Knappe-Drzikova, B., Vonderbeck, D., Jann, H., Weylandt, K.H., Grieser, C., Pascher, A., Schefold, J.C., Pavel, M., Wiedenmann, B., Sturm, A. and Pape, U.F.
Neuroendocrinology 104
(1): 11-25.
2017
2016
Docosapentaenoic acid derived metabolites and mediators-the new world of lipid mediator medicine in a nutshell.
Weylandt, K.H.
European Journal of Pharmacology 785
: 108-115.
15 August 2016
A lipidomic analysis approach in patients undergoing lipoprotein apheresis.
Schmoecker, C., Kassner, U., Kiesler, S., Bismarck, M., Rothe, M., Steinhagen-Thiessen, E. and Weylandt, K.H.
Atherosclerosis 249
: 30-35.
June 2016
2015
Omega-3 polyunsaturated fatty acids: the way forward in times of mixed evidence.
Weylandt, K.H., Serini, S., Chen, Y.Q., Su, H.M., Lim, K., Cittadini, A. and Calviello, G.
BioMed Research International 2015
: 143109.
2 August 2015
Effect of different omega-6/omega-3 polyunsaturated fatty acid ratios on the formation of monohydroxylated fatty acids in THP-1 derived macrophages.
Keeren, K., Huang, D., Smyl, C., Fischer, A., Rothe, M. and Weylandt, K.H.
Biology 4
(2): 314-326.
9 April 2015
Development of an online-SPE-LC-MS/MS method for 26 hydroxylated polyunsaturated fatty acids as rapid targeted metabolomics approach for the LOX, CYP, and autoxidation pathways of the arachidonic acid cascade.
Ostermann, A.I., Willenberg, I., Weylandt, K.H. and Schebb, N.H.
Chromatographia 78
(5-6): 415-428.
1 March 2015
ω-3 PUFAs in the prevention and cure of inflammatory, degenerative, and neoplastic diseases 2014.
Weylandt, K.H., Chen, Y.Q., Lim, K., Su, H.M., Cittadini, A. and Calviello, G.
BioMed Research International 2015
: 695875.
2015
2014
Dietary omega-3 fatty acids modulate the eicosanoid profile in man primarily via the CYP-epoxygenase pathway.
Fischer, R., Konkel, A., Mehling, H., Blossey, K., Gapelyuk, A., Wessel, N., von Schacky, C., Dechend, R., Muller, D.N., Rothe, M., Luft, F.C., Weylandt, K. and Schunck, W.H.
Journal of Lipid Research 55
(6): 1150-1164.
June 2014
2013
Acetylsalicylic acid reduces the severity of dextran sodium sulfate-induced colitis and increases the formation of anti-inflammatory lipid mediators.
Koehnke, T., Gomolka, B., Bilal, S., Zhou, X., Sun, Y., Rothe, M., Baumgart, D.C. and Weylandt, K.H.
BioMed Research International 2013
: 748160.
8 September 2013
Experimental evidence of ω-3 polyunsaturated fatty acid modulation of inflammatory cytokines and bioactive lipid mediators: their potential role in inflammatory, neurodegenerative, and neoplastic diseases.
Calviello, G., Su, H.M., Weylandt, K.H., Fasano, E., Serini, S. and Cittadini, A.
BioMed Research International 2013
: 743171.
2013
ω-3 PUFAs in the prevention and cure of inflammatory, degenerative, and neoplastic diseases.
Cittadini, A., Calviello, G., Su, H.M. and Weylandt, K.
BioMed Research International 2013
: 905986.
2013
This list was generated on Wed Nov 13 17:01:39 2024 UTC.